Page last updated: 2024-10-28

hydroxychloroquine and Atelectasis

hydroxychloroquine has been researched along with Atelectasis in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"While pleuropulmonary involvement in systemic lupus erythematosus (SLE) is a common occurrence, shrinking lung syndrome (SLS) is a rare complication of SLE, particularly in children."1.39Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl. ( Berner, R; Geiger, J; Heinzmann, A; Hufnagel, M; Meinicke, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meinicke, H1
Heinzmann, A1
Geiger, J1
Berner, R1
Hufnagel, M1

Other Studies

1 other study available for hydroxychloroquine and Atelectasis

ArticleYear
Symptoms of shrinking lung syndrome reveal systemic lupus erythematosus in a 12-year-old girl.
    Pediatric pulmonology, 2013, Volume: 48, Issue:12

    Topics: Chest Pain; Child; Cyclophosphamide; Diaphragm; Dyspnea; Female; Humans; Hydroxychloroquine; Immunos

2013